Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Effect of Diet and Selenium Supplementation on Macrophage Polarization

EF 2021-22

Résumé
Inflammatory bowel disease (IBD), consisting of ulcerative colitis and Crohns disease, is expected to affect 1% of Canadians by 2030. Currently, the exact cause nor cure is known, and these patients suffer from chronic pain and diarrhoea, life-long medication, and multiple surgeries. The leading theory is that the disease develops due to a dysfunctional relationship between the immune system and the normal bacterial inhabitants of the human intestinal tract. One aspect that affects this relationship is diet and there is a great amount of interest in IBD patients in modifying their diet to treat their disease. Therefore, a clinical trial led by Dr. Raman is exploring whether a therapeutic diet intervention (TDI) can induce remission in Crohns disease patients. This TDI is rich in the micronutrient selenium which is important for human health and immune system function. One way that selenium influences the immune system is through the immune cell known as macrophages, which can have both pro and anti-inflammatory actions. In macrophages derived from mice, it has been shown that selenium can help drive macrophages to an anti-inflammatory state, but this has not been shown yet in humans. Therefore, I hypothesize that dietary selenium supplementation can be a therapeutic approach to IBD by enhancing macrophage anti-inflammatory and pro-resolution (i.e. repair) capacity. To test this hypothesis, the direct affect of selenium and the TDI on macrophages will be determined. This project will contribute mechanistic insight to the TDI trial and further elucidate the role of seleniums interaction with the immune system. Ultimately this may lead to a complementary approach to treat patients with Crohns disease, a chronic disease with growing prevalence.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
467128
Name
Sousa James A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effect of Diet and Selenium Supplementation on Macrophage Polarization
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crohn'S Disease; Diet; Ibd; Macrophage; Polarization; Selenium
Abstract
Inflammatory bowel disease (IBD), consisting of ulcerative colitis and Crohns disease, is expected to affect 1% of Canadians by 2030. Currently, the exact cause nor cure is known, and these patients suffer from chronic pain and diarrhoea, life-long medication, and multiple surgeries. The leading theory is that the disease develops due to a dysfunctional relationship between the immune system and the normal bacterial inhabitants of the human intestinal tract. One aspect that affects this relationship is diet and there is a great amount of interest in IBD patients in modifying their diet to treat their disease. Therefore, a clinical trial led by Dr. Raman is exploring whether a therapeutic diet intervention (TDI) can induce remission in Crohns disease patients. This TDI is rich in the micronutrient selenium which is important for human health and immune system function. One way that selenium influences the immune system is through the immune cell known as macrophages, which can have both pro and anti-inflammatory actions. In macrophages derived from mice, it has been shown that selenium can help drive macrophages to an anti-inflammatory state, but this has not been shown yet in humans. Therefore, I hypothesize that dietary selenium supplementation can be a therapeutic approach to IBD by enhancing macrophage anti-inflammatory and pro-resolution (i.e. repair) capacity. To test this hypothesis, the direct affect of selenium and the TDI on macrophages will be determined. This project will contribute mechanistic insight to the TDI trial and further elucidate the role of seleniums interaction with the immune system. Ultimately this may lead to a complementary approach to treat patients with Crohns disease, a chronic disease with growing prevalence.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sousa, James A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~